Managing and Monitoring Infections and Neurological Toxicities in Patients Receiving Bispecific Therapies

Opinion
Video

Dr. Mohan discusses with Nurse Goff and Nurse Brigle the prevention and management of infections and neurological toxicities in patients receiving bispecific therapies, with a particular focus on the unique considerations of talquetamab targeting GPRC5D.

Video content above is prompted by the following:

  • How do you approach the prevention and management of infections in patients receiving bispecific therapies, particularly considering the unique target of talquetamab (GPRC5D)?
  • What are your protocols for monitoring and managing neurological toxicities in patients receiving bispecific therapies?
    • Are there any specific considerations for talquetamab?
Recent Videos
Smiling woman in front of a blue video call background with logos that say "All in Against Cancer" and "Ochsner Health" above her
Man standing in front of Oncology Nursing News-branded backdrop
Image of a woman in an office, taken as a screenshot from the video interview
woman in front of a dark blue background for Oschner Health
Related Content